This November, as consumers set out to enroll in health insurance plans in the United States, many will find yet another challenge as insures add another generic drug tier to their prescription drug plan. Not only will this mean higher out-of-pocket expenses for consumers, but critics argue that even small price changes effect medical behavior, and will result in a lower quality of care. Read more here, and lets us know what you think about this new scheme. (Source: Trudy Lieberman, medpageTODAY’S KevinMD.com, 10/9/14).
You are here: / / The Dangers Of Two-Tiered Generic Drug Plans